Study Title | A randomised and open-label and active controlled and safety and extrapolated efficacy study in paediatric subjects requiring anticoagulation for the treatment of a venous thromboembolic event (Phase IV) Apixaban |
---|---|
Protocol ID | B0661037 |
Disease (Sub Disease) | Venous Thromboembolism |
Diagnosis Stage | New Diagnosis Relapse/Refractory |
Location | NSW |
Sponsor | Pfizer |
Collaborators | Bristol-Myers Squibb |
Links | https://clinicaltrials.gov/ct2/show/NCT02464969 |
Trial Status | Open |
Trial Open Date | 02/08/2018 |
Sites | Sydney Children's Hospital |
Study Type | Treatment |
Phase | Phase 4 |
Age Eligibility | 3 Months to 17 Years |
International registry ID's | NCT02464969 |